A Double-blind, Vehicle-controlled Study to Assess the Safety, Tolerability, and Efficacy of Three Weeks of Daily Dermal Application of MRX-6 (2% HyPE) on the Treatment of Mild to Moderate Contact Dermatitis of the Hand and Forearm
Latest Information Update: 14 Jan 2020
At a glance
- Drugs MRX 6 (Primary) ; Corticosteroids
- Indications Allergic contact dermatitis
- Focus Adverse reactions
- 20 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 10 Dec 2013 New trial record